Scopus by Title (Ref)

Pertussis in Early Infancy: Diagnostic Challenges, Disease Burden, and Public Health Implications Amidst the 2024 Resurgence, with Emphasis on Maternal Vaccination Strategies

Vaccines

March 2025

Leontari K.

Open Access

Safety and efficacy of a Bordetella bronchiseptica outer membrane proteins (OMPs) subunit vaccine in a murine model

Journal of Veterinary Science

2025

Jang J.Y.

Open Access

Development and Evaluation of Five-in-One Vaccine Microneedle Array Patch for Diphtheria, Tetanus, Pertussis, Hepatitis B, and Haemophilus influenzae Type b: Immunological Efficacy and Long-Term Stability

Pharmaceutics

December 2024

Choi I.J.

Open Access

Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges

Vaccines

June 2024

Kumar P.

Open Access

Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations

Clinical Microbiology Reviews

September 2023

Chamorro B.M.

Open Access

Pertussis vaccines and the role of Bordetella pertussis lipooligosaccharide in the immune response to pertussis infection and vaccination

Biopreparations Prevention Diagnosis Treatment

2021

Alekseeva I.A.

Open Access

Cell-mediated and humoral immune responses to Bordetella pertussis inactivated whole-cells encapsulated alginate microspheres as a new vaccine candidate

Current Pharmaceutical Biotechnology

2017

Dounighi N.M.

A new vaccine delivery vehicle and adjuvant candidate: Bordetella pertussis inactivated whole cells entrapped in alginate microspheres

Current Pharmaceutical Design

2017

Dounighi N.M.

Low-dose Thimerosal in pediatric vaccines: Adverse effects in perspective

Environmental Research

1 January 2017

Dórea J.G.